drugset / Trial / NCT06254274
A Study of RAY1225 in Participants With Type 2 Diabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
The main purpose of this study is to learn more about the Tolerability of RAY1225 in participants with type 2 diabetes mellitus. The study will also explore the efficacy of RAY1225. The study will last about six months for each participant.
Timeline
- Start
- 2024-02-26
- Primary completion
- 2025-12-20
- Completion
- 2025-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RAY1225 | Unknown | — | Subcutaneous |